Clinical Trials Logo

Clinical Trial Summary

The investigators aim to establish wether the administration of pancreatic enzyme replacement therapy (PERT) improves visibility of the mucosa during upper gastrointestinal endoscopy.


Clinical Trial Description

Upper gastrointestinal endoscopy is done "a jeun", without any solid foods at least 8 hours before procedure and no water at least 2 hours before procedure. Often, the visibility of the mucosa is suboptimal due to presence of saliva which lay on the surface of the gastric mucosa forming small bubbles of foam and also the presence of mucus on the mucosal surface. Current strategies to improve mucosa visibility includes ingestion of simethicone, N-acetyl cysteine (N-ACC) an/or pronase, in different combinations, with 10 to 30 minutes before procedure. There are numerous comparative studies which shows their efficacy [1,2,3,4]. Although the guide of the European Society of Gastrointestinal Endoscopy (ESGE) [5] does not formally recommend these, the United Kingdom and the Australian guidelines do formally recommend them [6]. În România simethicone is available, but not pronase. Research question of the protocol Does ingestion of a pancreatic protease (KREON 25000 UI) before upper GI endoscopy improves the visibility of the gastric mucosa. Hypothesis Ingestion of a pancreatic protease (KREON 25000 UI) before upper GI endoscopy improves the visibility score of the gastric mucosa. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06218537
Study type Interventional
Source Carol Davila University of Medicine and Pharmacy
Contact Mihai Ciocirlan
Phone 0040722322625
Email ciocirlanm@yahoo.com
Status Recruiting
Phase N/A
Start date May 6, 2024
Completion date June 2024

See also
  Status Clinical Trial Phase
Completed NCT02863861 - Sedation for Upper Gastrointestinal Endoscopy in Pediatric Patients Phase 4
Completed NCT03280784 - Clinical Audit on the Use of Upper Endoscopy in Assist University Children Hospital
Recruiting NCT06220175 - Pharynx Analgesia Before Upper Gastrointestinal Endoscopy N/A
Completed NCT01471600 - Safety and Efficacy of Carbohydrate Drink Ingested Two Hours Before Upper Endoscopy Under General Anaesthesia N/A
Recruiting NCT04593836 - Antiperistaltic Effect and Safety of L-menthol in the Elderly With Contraindication to Buscopan Phase 3